Saralasin [saralasin]
- Terms
 - 
            
(Sar(1),Ala(8))ANGII
(Sar1,Val5,Ala8)Angiotensin II
1-Sar-8-Ala Angiotensin II
1-Sarcosine-8-Alanine Angiotensin II
Angiotensin II, Sar(1)-Ala(8)-
Angiotensin II, Sarcosyl(1)-Alanine(8)-
Sar-Arg-Val-Tyr-Val-His-Pro-Ala
Saralasin Acetate
Saralasin Acetate, Anhydrous
Saralasin Acetate, Hydrated 
An octapeptide analog of angiotensin II (bovine) with amino acids 1 and 8 replaced with sarcosine and alanine, respectively. It is a highly specific competitive inhibitor of angiotensin II that is used in the diagnosis of HYPERTENSION.
- DUI
 - D012504 MeSH Browser
 - CUI
 - M0019423
 - CAS
 - Angiotensin II, 1-(N-methylglycine)-5-L-valine-8-L-alanine-
 - Previous indexing
 - Alanine (1974); Angiotensin II (1974); Sarcosine (1974)
 - History note
 - 1984(1978)
 - Public note
 - 1984; see ANGIOTENSIN II 1978-83; 1-SARCOSINE-8-ALANINE ANGIOTENSIN II was indexed under ANGIOTENSIN II 1975-77
 
Allowable subheadings
- AD
 - administration & dosage 1
 - AE
 - adverse effects
 - AG
 - agonists
 - AA
 - analogs & derivatives
 - AN
 - analysis
 - AI
 - antagonists & inhibitors
 - BI
 - biosynthesis
 - BL
 - blood
 - CF
 - cerebrospinal fluid
 - CS
 - chemical synthesis
 - CH
 - chemistry
 - CL
 - classification
 - DF
 - deficiency
 - DE
 - drug effects
 - EC
 - economics
 - GE
 - genetics
 - HI
 - history
 - IM
 - immunology
 - IP
 - isolation & purification
 - ME
 - metabolism
 - PK
 - pharmacokinetics
 - PD
 - pharmacology 1
 - PH
 - physiology
 - PO
 - poisoning
 - RE
 - radiation effects
 - ST
 - standards
 - SD
 - supply & distribution
 - TU
 - therapeutic use
 - TO
 - toxicity
 - UR
 - urine